Nanotherapeutics in transplantation: How do we get to clinical implementation?

Plumblee, Leah; Atkinson, Carl; Jaishankar, Dinesh; Scott, Evan; Tietjen, Gregory T; Nadig, Satish N

Plumblee, Leah; Atkinson, Carl; Jaishankar, Dinesh; Scott, Evan; Tietjen, Gregory T; Nadig, Satish N.

Afiliação

Plumblee L; Department of Microbiology and Immunology, Medical University of South Carolina, Charleston, South Carolina.
Atkinson C; Department of Surgery, Division of Transplant Surgery, Medical University of South Carolina, Charleston, South Carolina.
Jaishankar D; Department of Microbiology and Immunology, Medical University of South Carolina, Charleston, South Carolina.
Scott E; Division of Pulmonary, Critical Care, and Sleep Medicine, University of Florida, Gainesville, Florida.
Tietjen GT; Department of Surgery, Division of Transplant Surgery, Medical University of South Carolina, Charleston, South Carolina.
Nadig SN; Department of Biomedical Engineering, Northwestern University, Evanston, Illinois.

Am J Transplant ; 22(5): 1293-1298, 2022 05.

Article em En | MEDLINE | ID: mdl-35224837

Assuntos

Imunossupressores; Transplante de Órgãos; Rejeição de Enxerto/tratamento farmacológico; Rejeição de Enxerto/prevenção & controle; Humanos; Tolerância Imunológica; Terapia de Imunossupressão; Imunossupressores/uso terapêutico

Palavras-chave

basic (laboratory) research/science; bioengineering; graft survival; immunosuppressant; immunosuppression/immune modulation; organ perfusion and preservation; organ transplantation in general; solid organ transplantation; translational research/science

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Transplante de Órgãos / Imunossupressores Limite: Humans Idioma: En Revista: Am J Transplant Assunto da revista: TRANSPLANTE Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google